Delivery Order SPE2DR25D3004-SPE2DR26FXUR2
Award Date 1/21/26
Potential Completion Date 1/22/26
Potential Value $6.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order on January 13, 2026, by the Defense Logistics Agency to supply 90 tablets of Jardiance 10 mg, a diabetes medication. This $4,270.31 firm fixed-price contract is a non-set-aside award, demonstrating AmerisourceBergen's competitive capability to serve federal medical procurement requirements. The order is scheduled for completion by January 14, 2026, with performance taking place at the company's corporate...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order on January 16, 2026, valued at $14,720.89 for the supply of Jardiance 10 mg tablets (90-count packages) to the Defense Logistics Agency. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 20, 2026. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,078.93 on January 20, 2026, to supply Jardiance 25 mg tablets (90-count) to the Defense Logistics Agency with an ultimate completion date of January 21, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order on January 20, 2026, by the Defense Logistics Agency (DLA) for the supply of Jardiance 25 mg tablets in a quantity of 90 units, with a ceiling value of $6,531.95 and a firm fixed price contract type. The order is scheduled for completion by January 21, 2026, and will be performed at the contractor's Conshohocken, Pennsylvania facility. This delivery order carries no set-aside designation, indicating it was...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $3,789.84 by the Defense Logistics Agency on January 13, 2026, for the supply of Jardiance 25 mg tablets in quantities of 90 units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 14, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under Amerisourcebergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 15, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Jardiance 10 mg tablets (90-count packaging). The contract carries a ceiling value of $48,577.98 and employs firm fixed price terms with an ultimate completion date of August 18, 2025. This non-set-aside award was competitively awarded and represents a child delivery order...
- AmerisourceBergen Drug Corp was awarded a competitive delivery order on September 17, 2025, by the Defense Logistics Agency (DLA) to supply 90 tablets of Jardiance 25 mg, a diabetes medication, with a firm fixed price of $44,282.74 and an ultimate completion date of September 18, 2025. This award represents a child delivery order placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $26,925.68 on January 16, 2026, for the supply of Jardiance 25 mg tablets (90-count packages) to support federal medical procurement needs. This firm fixed-price delivery order, which must be completed by January 20, 2026, carries no set-aside designation and was competitively awarded. The Defense Logistics Agency, which funds the award, procures pharmaceutical products through Amerisourcebergen...
- The Defense Logistics Agency awarded a delivery order valued at $6,274.13 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on January 8, 2026, with an ultimate completion date of January 9, 2026. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award on a full and open basis. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on November 6, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $11,878.85. This competitive, firm fixed-price delivery order is set to be completed by November 7, 2025, and represents a single-line procurement under AmerisourceBergen's larger pharmaceutical supply framework with the federal...